Determination of HER2/neu status in uterine serous papillary carcinoma: Comparative analysis of immunohistochemistry and fluorescence in situ hybridization
2005 · Gynecologic Oncology · 93 citations
https://doi.org/10.1016/j.ygyno.2005.03.041
E
Erming Tian
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
101
Papers
5.4K
Citations
31
h-index
41
i10-index
Erming Tian is an academic researcher from Winthrop Rockefeller Foundation. The author has contributed to research in topics: Multiple Myeloma Research and Treatments & Protein Degradation and Inhibitors & Glycosylation and Glycoproteins Research. The author has an h-index of 31, co-authored 86 publications.
Papers by this author
worksThe level of deletion 17p and bi-allelic inactivation of <i>TP53</i> has a significant impact on clinical outcome in multiple myeloma
2017 · Haematologica · 78 citations
https://doi.org/10.3324/haematol.2017.168872
An acquired high-risk chromosome instability phenotype in multiple myeloma: Jumping 1q Syndrome
2019 · Blood Cancer Journal · 36 citations
https://doi.org/10.1038/s41408-019-0226-4
Erythropoietin (EPO)-receptor signaling induces cell death of primary myeloma cells in vitro
2016 · Journal of Hematology & Oncology · 14 citations
https://doi.org/10.1186/s13045-016-0306-x
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat